Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 11,567 | 10,053 | 8,572 | 8,510 | 3,632 |
| Cost of Goods | 3,133 | 1,338 | 1,051 | 1,013 | 1,186 |
| Gross Profit | 8,434 | 8,715 | 7,521 | 7,497 | 2,446 |
| Operating Expenses | 60,557 | 70,943 | 48,886 | 49,565 | 51,931 |
| Operating Income | -51,990 | -61,890 | -41,314 | -42,055 | -49,299 |
| Interest Expense | 0 | 2,907 | 0 | 0 | 1,030 |
| Other Income | -275 | 2,307 | -552 | -744 | 0 |
| Pre-tax Income | -52,265 | -62,490 | -41,866 | -42,799 | -50,329 |
| Net Income Continuous | -52,265 | -62,490 | -41,866 | -42,799 | -50,329 |
| Net Income | $-52,265 | $-62,490 | $-41,866 | $-42,799 | $-50,329 |
| EPS Basic Total Ops | -0.81 | -1.08 | -0.77 | -0.80 | -1.00 |
| EPS Basic Continuous Ops | -0.81 | -1.09 | -0.77 | -0.80 | -1.00 |
| EPS Diluted Total Ops | -0.81 | -1.08 | -0.77 | -0.80 | -1.00 |
| EPS Diluted Continuous Ops | -0.81 | -1.09 | -0.77 | -0.80 | -1.00 |
| EBITDA(a) | $-51,610 | $-61,321 | $-40,804 | $-41,609 | $-48,798 |